Differences in the primary care management of patients with psychosis from two ethnic groups: A population-based cross-sectional study

Family Practice

Volumn 27, Issue 4, 2010, Pages 439-446

  Pinto, Rebecca ^a   Ashworth, Mark ^a   Seed, Paul ^a   Rowlands, Gill ^b   Schofield, Peter ^a   Jones, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

Author keywords

Health informatics; Mental health; Prescribing

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; ETHNIC DIFFERENCE; FEMALE; GENERAL PRACTICE; HEALTH CARE MANAGEMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOME ASSESSMENT; PATIENT MONITORING; PRESCRIPTION; PREVALENCE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING CESSATION;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIAGNOSTIC TESTS, ROUTINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LONDON; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 77955262372     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmq014     Document Type: Article

References (35)

1. Bresnahan M, Menezes P, Varma V, Susser E. Geographical variation in incidence, course and outcome of schizophrenia: a comparison of developing and developed countries. In: Murray RM, Jones PB, Susser E, van Os J, Cannon M (eds). The Epidemiology of Schizophrenia, Cambridge: Cambridge University Press, 2003, pp. 5-17.
2. Harrison G, Holton A, Neilson D et al. Severe mental disorder in Afro-Caribbean patients: some social, demographic and service factors. Psychol Med 1989; 19: 683-96.
3. Pinto R, Ashworth M, Jones R. Schizophrenia in Black Caribbeans living in the UK: an exploration of underlying causes of the high incidence rate. Br J Gen Pract 2008; 58: 429-34.
4. Fearon P, Kirkbride J, Morgan C et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC ÆSOP Study. Psychol Med 2006; 36: 1541-50.
5. Morgan C, Mallett R, Hutchinson G, Leff J. Negative pathways to psychiatric care and ethnicity: the bridge between social science and psychiatry. Soc Sci Med 2004; 58: 739-52.
6. Bhugra D, Harding C, Lippett R. Pathways into care and satisfaction for black patients in south London. J Ment Health 2004; 13: 171-83.
7. Cappucio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78: 555-63.
8. Friedli L, Jenkins R, McCulloch A, Parker C. Developing a National Mental Health Policy. Maudsley Monographs. London: Psychology Press, 2002.
9. Kumarapeli P, Stephaniuk R, de de Lusignan S et al. Ethnicity recording in general practice computer systems. Journal of Public Health 2006; 28: 283-7.
10. National Statistics: Census 2001. http://www.statistics.gov.uk/ census2001/profiles/1b.asp (accessed on 7 March 2010).
11. Garety PA, Rigg A. Early psychosis in the inner city: a survey to inform service planning. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 537-44.
12. The Information Centre. The Quality and Outcomes Framework (QOF). Leeds: Department of Health, 2007. http://www.ic.nhs. uk/statistics-and-data-collections/audits-and-performance/thequality-and-outcomes-framework-qof (accessed on 7 March 2010).
13. The English indices of deprivation. 2004. summary (revised). London: Office of the Deputy Prime Minister, 2004. http:// www.communities.gov.uk/archived/publications/communities/ indicesdeprivation (accessed on 7 March 2010).
14. Walkup JT, McAlpine DD, Olfson M et al. Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry 2000; 61: 344-8.
15. Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 2002; 159: 567-72.
16. Arnold LM, Strakowski SM, Schwiers ML et al. Sex, ethnicity, and antipsychotic medication use in patients with psychosis. Schizophr Res 2004; 66: 169-75.
17. Dencker S, Axelsson R. Optimising the use of depot antipsychotics. CNS Drugs 1996; 6: 367-81.
18. Ziguras S, Lambert TJR, McKenzie DP, Pennella J. The influence of client's ethnicity on psychotropic medication management in community mental health services. Aust N Z J Psychiatry 1999; 33: 882-8.
19. Barnes TRE, Shingleton-Smith A, Pat C. Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiatry 2009; 195: s37-42.
20. West JC, Marcus SC, Wilk J et al. Use of depot antipsychotic medications for medication nonadherence in schizophrenia. Schizophr Bull 2008; 34: 995-1001.
21. Valenstein M, Copeland LA, Owen R et al. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J Clin Psychiatry 2001; 62: 545-51.
22. Goad JD, Ezell JR. Drug-use evaluation programs for psychotropic medications. Am J Hosp Pharm 1990; 47: 132-6.
23. Windgassen K. Treatment with neuroleptics: the patient's perspective. Acta Psychiatr Scand 1992; 86: 405-10.
24. Chapman T, Mulvihill E. Out-patients' perceptions of the clinical and psychosocial effects of neuroleptic medication. Psychiatr Bull 1990; 14: 331-2.
25. Pereira S, Pinto R. A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand 1997; 95: 464-8.
26. Nasrallah HA, Meyer JM, Goff DC et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006; 86: 15-22.
27. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophr Bull 1998; 24: 11-20.
28. McKenzie K, Samele C, van Horn E et al. Comparison of the outcome and treatment of psychosis in people of Caribbean origin living in the UK and British Whites. Br J Psychiatry 2001; 178: 160-5.
29. Nazareth I, King M, Haines A et al. Accuracy of diagnosis of psychosis on general practice computer system. BMJ 1993; 307: 32-4.
30. Meal AG, Pringle M, Hammersley V. Time changes in new cases of ischaemic heart disease in general practice. Fam Pract 2000; 17: 394-400.
31. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric Morbidity Among Adults Living in Private Households, 2000. London: The Stationery Office, 2001.
32. Regier DA, Narrow WE, Rae DS et al. The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50: 85-94.
33. Sanne GHA, Swinnen A, Selten J-P. Mood disorders and migration: meta-analysis. Br J Psychiatry 2007; 190: 6-10.
34. Cantor-Graae E, Selten JP. Schizophrenia and migration: a metaanalysis and review. Am J Psychiatry 2005; 162: 12-24.
35. Gervas J, Perez Fernandez M, Starfield BH. Primary care, financing and gatekeeping in western Europe. Fam Pract 1994; 11: 307-17.